Qube Research & Technologies (QRT)’s RAPT Therapeutics RAPT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-158,292	Closed	-$5.36M	–	4011
2025 Q4	$5.36M	Buy	+158,292	New	+$4.92M	0.01%	1728
2023 Q4	–	Sell	-4,980	Closed	-$662K	–	4662
2023 Q3	$662K	Sell	4,980 -8,419	-63%	-$1.37M	﹤0.01%	1904
2023 Q2	$2M	Buy	13,399 +948	+8%	+$148K	0.01%	1055
2023 Q1	$1.83M	Buy	+12,451	New	+$2.52M	0.01%	1045

Qube Research & Technologies (QRT)'s RAPT Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 158,292 shares — an estimated $5.36M sold.

Qube Research & Technologies (QRT) first reported a position in RAPT in Q1 2023 and held it in 4 quarters. The position peaked at $5.36M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Qube Research & Technologies (QRT) reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 158,292 RAPT Therapeutics shares in Q1 2026, an estimated $5.36M.
Qube Research & Technologies (QRT) first reported a position in RAPT Therapeutics in Q1 2023 and held it in 4 quarters.
Qube Research & Technologies (QRT)'s RAPT Therapeutics position peaked at $5.36M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.